Peifen Cai
Jiangsu Cancer Hospital(CN)
Publications by Year
Research Areas
Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Inflammasome and immune disorders, Histone Deacetylase Inhibitors Research, Galectins and Cancer Biology
Most-Cited Works
- → Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer(2014)306 cited
- → Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response(2014)80 cited
- → Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog(2014)60 cited
- → Axitinib augments antitumor activity in renal cell carcinoma via STAT3-dependent reversal of myeloid-derived suppressor cell accumulation(2014)57 cited
- → Transmembrane-Bound IL-15–Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway(2015)40 cited
- → Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer(2013)37 cited
- → Axitinib, a selective inhibitor of vascular endothelial growth factor receptor, exerts an anticancer effect in melanoma through promoting antitumor immunity(2013)32 cited
- → Icotinib, a potent and specific EGFR tyrosine kinase inhibitor, inhibits growth of squamous cell carcinoma cell line A431 through negatively regulating AKT signaling(2013)22 cited
- → Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice(2021)20 cited
- → Efficacy of combined axitinib with dacarbazine in a B16F1 melanoma xenograft model(2013)14 cited